Everything tagged "nasdaq" across the TickerSpark archives.
Falcon's Beyond Global, Inc. 8% Series A Preferred Stock is expected to list on NASDAQ on 2026-05-21, but the price range has not been disclosed. The key question is whether investors focus on the company’s destination and IP platform or on its uneven financial profile and liquidity history.
RIKU DINING GROUP Ltd. is expected to list on NASDAQ on 2026-05-27, with shares priced at $4.00 to $6.00. The company is offering 5,000,000 shares, implying a $20 million to $30 million primary raise before expenses. The setup favors investors who want a small, cross-border restaurant story with visible unit economics, but they should watch the margin pressure, control structure, and Hong Kong regulatory exposure.
Octave Intelligence plc Class B Ordinary Shares When Issued is expected to list on NASDAQ on 2026-05-21, but the price range has not been disclosed. This is a spin-off listing from Hexagon AB, not a traditional cash-raising IPO. The setup favors investors who want a large installed base and recurring revenue, while shareholders should watch the independent-company execution and any post-distribution selling pressure.
Aperture AC (NASDAQ: APURU) is expected to list on 2026-05-21, with a price range not yet disclosed. The SPAC is offering 9,000,000 units and is targeting a $103.5 million market cap if the over-allotment is fully exercised. The setup is simple: the appeal is exposure to digital-asset infrastructure, while the main question is whether the sponsor can source a credible deal before the clock runs out.
Conexeu Sciences Inc. (NASDAQ: CNXU) is expected to list on 2026-05-21, with the price range not yet disclosed. The setup is a preclinical regenerative medicine story with no FDA-cleared product yet, so shareholders should watch for pricing, dilution, and how the market values the pipeline risk.
Optimi Health Corp. (NASDAQ: OPTH) is expected to list on 2026-05-20, with a price range not disclosed and 2,500,000 shares offered. The setup is a small, early commercial psychedelic manufacturer with real revenue, but it is still carrying losses, a working capital deficit, and heavy regulatory dependence.
AMASS Brands Inc. Common Stock (NASDAQ: AMSS) is expected to list on 2026-05-20, but the price range has not been disclosed. This is a direct listing, so the setup is less about fresh capital and more about whether investors want exposure to a small premium beverage platform with losses and limited cash.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime